CARA THERAPEUTICS, INC. CARA Balance Sheet

Cara therapeutics, inc. (CARA)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13
Assets
Current assets:
Cash and cash equivalents
17,036	18,305	34,705	18,494	14,188	15,081	96,729	17,802	11,877	9,388	11,792	9,416	5,306	12,092	5,426	3,545	7,922	15,101	111,116	43,191	47,422	52,663	58,393	62,812	67,038	12,357
Marketable securities
103,160	136,701	158,384	96,815	120,265	146,302	109,348	114,159	62,644	83,181	91,190	103,020	31,504	46,184	65,994	81,219	88,322	91,640	-	-	-	-	-	-	-	-
Income tax receivable
938	816	1,033	984	749	664	539	473	777	731	705	560	558	852	663	608	529	384	450	250	215	200	89	57	46	61
Other receivables
847	971	784	605	1,019	926	193	116	84	123	97	175	984	87	115	373	128	80	2,143	-	-	-	-	480	-	-
Prepaid expenses
10,688	8,863	8,556	7,512	7,577	4,805	4,218	5,615	3,431	1,635	1,492	1,934	1,979	1,530	4,820	3,398	2,573	1,729	1,971	590	1,420	287	928	1,706	1,142	2,140
Restricted cash, current
-	-	-	361	361	361	361	361	-	-	700	700	700	700	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets
132,669	165,656	203,462	124,771	144,159	168,139	211,388	138,526	78,813	95,058	105,976	115,805	41,031	61,445	77,018	89,143	99,474	108,934	115,680	44,031	49,057	53,150	59,410	65,055	68,226	14,558
Operating lease right-of-use asset
2,876	3,036	3,192	3,344	3,492	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Marketable securities, non-current
59,568	63,159	55,985	20,320	21,687	21,396	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment, net
652	700	748	798	841	880	908	959	1,053	1,177	1,302	1,399	1,499	1,614	1,665	1,433	1,070	1,263	1,517	1,710	1,897	2,084	2,262	2,439	2,629	2,825
Restricted cash
408	408	408	408	408	408	408	408	769	769	769	769	769	769	1,469	1,469	1,469	700	700	700	700	700	700	700	700	700
Total assets
196,173	232,959	263,795	149,641	170,587	190,823	212,704	139,893	80,635	97,004	108,047	117,973	43,299	63,828	80,152	92,045	102,013	110,897	117,897	46,441	51,654	55,934	62,372	68,194	71,555	18,083
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued expenses
17,371	19,665	20,581	12,766	13,310	13,622	14,003	12,553	6,875	8,506	7,272	7,190	12,512	11,533	6,825	8,168	6,089	5,268	3,374	3,150	2,464	1,946	4,149	2,548	2,336	1,958
Operating lease liability, current
991	967	945	923	901	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of deferred revenue
14,241	22,262	26,773	26,473	28,194	26,825	29,242	22,270	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	89	963	1,452	1,944	3,069	3,417	3,475
Total current liabilities
32,603	42,894	48,299	40,162	42,405	40,447	43,245	34,823	6,875	8,506	7,272	7,190	12,512	11,533	6,825	8,168	6,089	5,268	3,374	3,239	3,427	3,398	6,093	5,617	5,753	5,433
Operating lease liability, non-current
3,096	3,352	3,602	3,849	4,087	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, non-current
-	-	0	6,085	9,573	15,184	18,300	30,299	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred lease obligation
-	-	-	-	-	1,562	1,629	1,695	1,657	1,718	1,701	1,563	1,518	1,570	1,525	1,289	997	585	660	732	803	874	944	1,009	1,074	1,139
Commitments and contingencies (Note 15)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Convertible Preferred stock; $0.001 par value; zero shares and 29,402,200 shares authorized at December 31, 2014 and December 31, 2013, respectively; zero shares and 29,186,929 shares at December 31, 2014 and December 31, 2013 issued and outstanding, respectively; aggregate liquidation preference of zero and $65,969 at December 31, 2014 and December 31, 2013, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	65,586
Stockholders' equity:
Preferred stock; $0.001 par value; 5,000,000 shares authorized at March 31, 2020 and December 31, 2019, zero shares issued and outstanding at March 31, 2020 and December 31, 2019
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized at March 31, 2020 and December 31, 2019, 46,727,725 shares and 46,720,225 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
47	47	46	40	39	39	39	34	33	33	33	33	27	27	27	27	27	27	27	23	23	23	23	23	23	4
Common stock subscribed in follow-on offering; $0.001 par value; 5,117,500 shares at March 31, 2017
-	-	-	-	-	-	-	-	-	-	-	-	5	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional paid-in capital
590,144	587,223	583,811	438,614	430,724	428,059	423,180	327,401	309,292	307,158	305,165	302,920	300,151	212,866	211,954	211,177	210,479	209,943	209,197	133,021	132,291	131,840	131,341	131,029	130,544	8,377
Subscriptions receivable
-	-	-	-	-	-	-	-	-	-	-	-	86,518	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated deficit
-429,649	-400,727	-372,116	-339,274	-316,314	-294,354	-273,702	-254,302	-237,108	-220,341	-206,164	-193,720	-184,420	-162,171	-140,199	-128,657	-115,583	-104,891	-95,361	-90,574	-84,890	-80,201	-76,029	-69,484	-65,839	-62,456
Accumulated other comprehensive income (loss)
-68	170	153	165	73	-114	13	-57	-114	-70	40	-13	24	3	20	41	4	-35	-	-	-	0	-	-	-	-
Total stockholders' equity
160,474	186,713	211,894	99,545	114,522	133,630	149,530	73,076	72,103	86,780	99,074	109,220	29,269	50,725	71,802	82,588	94,927	105,044	113,863	42,470	47,424	51,662	55,335	61,568	64,728	-54,075
Total liabilities and stockholders' equity
196,173	232,959	263,795	149,641	170,587	190,823	212,704	139,893	80,635	97,004	108,047	117,973	43,299	63,828	80,152	92,045	102,013	110,897	117,897	46,441	51,654	55,934	62,372	68,194	71,555	18,083